140 results on '"Leach, Michael J."'
Search Results
2. Rural nurses’ self-rated knowledge and skills in pain, medication, symptom and emergency management in community-based palliative care: A cross-sectional survey
3. Physical activity, obesity, and quality of life among rural Australian cancer survivors: a cross-sectional study
4. Functional outcomes following an in-hospital cardiac arrest: A retrospective cohort study
5. A data visualisation method for assessing exposure misclassification in case-crossover studies: the example of tricyclic antidepressants and the risk of hip fracture in older people
6. Dx
7. The Risk of Hip Fracture Due to Mirtazapine Exposure When Switching Antidepressants or Using Other Antidepressants as Add-On Therapy
8. Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case–Control Study in Australia
9. N of 1
10. Rural nurses’ self-rated knowledge and skills in pain, medication, symptom and emergency management in community-based palliative care: A cross-sectional survey
11. The Warmth of Her Light
12. Level and correlates of social support in a community‐based sample of Australians who primarily smoke methamphetamine
13. Clinical pharmacy: Medicine use among the elderly before and after hip fracture
14. A Villanelle on the Infinitesimal
15. Science calligrams: A contemporary science communication perspective
16. Psychoactive medicine use and the risk of hip fracture in older people: a case-crossover study†
17. The Uncertainty of Confidence
18. Central Nervous System Drugs: Low Temperature X-ray Structures of (I) the Base 5-(2,3-Dichlorophenyl)-2,4-diamino-6-fluoromethyl-pyrimidine (4030W92) and (II) 5-(2,6-Dichlorophenyl)-1-H-2,4-diamino-6-methyl-pyrimidine methanesulphonic acid salt (227C89)
19. Low Temperature X-ray Structures of Two Crystalline Forms (I) and (II) of the Pyrimidine Derivative and Sodium Channel Blocker BW1003C87: 5-(2,3,5-Trichlorophenyl)-2,4-diaminopyrimidine
20. X-ray Crystallographic Structures of Two Lamotrigine Analogues: (I) 3,5-Diamino-6-(2-chlorophenyl)-1,2,4-triazine Water Solvate and (II) 3,5-Diamino-6-(3,6-dichlorophenyl)-1,2,4-triazine Methanol Solvate
21. Low Temperature X-ray Crystallographic Structures of Two Lamotrigine Analogues: (I) 2-Methyl,3-amino, 5-imino-6-(2,3-dichlorophenyl)-1,2,4-triazine Water Solvate and (II) 2-Methyl,3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine Isethionate, Hemi-hydrate
22. Factors Associated with Quality of Life Among People Living With a Stoma in Nonmetropolitan Areas
23. Medicine Use among Older Australians Before and After Hip Fracture
24. X-ray Crystallographic Structures of Neuroprotective Pyrimidine Derivatives: (I) the Mesylate Salt of BW1003C87 and (II) Sipatrigine Base
25. Structure of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate solvate (lamotrigine isethionate)
26. Factors associated with quality of life in 7-year survivors of stroke
27. THE NEUROPROTECTIVE AGENT SIPATRIGINE BLOCKS MULTIPLE CARDIAC ION CHANNELS AND CAUSES TRIANGULATION OF THE VENTRICULAR ACTION POTENTIAL
28. Retinal Hemorrhages in Acute Leukemia
29. A Villanelle on the Infinitesimal
30. BW619C89, a Glutamate Release Inhibitor, Protects Against Focal Cerebral Ischemic Damage
31. The risk of hip fracture in older people using selective serotonin reuptake inhibitors (SSRIs) and other psychoactive medicines concurrently
32. Shaping the Fractured Self: Poetry of Chronic Illness and Pain.
33. Mass Caffeination.
34. A Vestige of Architectural History: The Lansell Laboratory Building.
35. Poetry of Encounter: The Liquid Amber Prize Anthology.
36. Doctor Poets & Other Healers: COVID in Their Own Words.
37. Krill Watching.
38. Undercoat.
39. Longitudinal
40. An Adaptive Motion Model for Person Tracking with Instantaneous Head-Pose Features
41. Gathering STEAM in Health Care: A Student History.
42. Human Looking.
43. An absolute structure template for a unique voltage-gated sodium channel binding site
44. Central Nervous System Drugs: Low Temperature X-ray Structures of (I) the Base 5-(2,3-Dichlorophenyl)-2,4-diamino-6-fluoromethyl-pyrimidine (4030W92) and (II) 5-(2,6-Dichlorophenyl)-1-H-2,4-diamino-6-methyl-pyrimidine methanesulphonic acid salt (227C89)
45. Sipatrigine (BW 619C89) is a Neuroprotective Agent and a Sodium Channel and Calcium Channel Inhibitor
46. A Novel Drug Binding Site on Voltage-Gated Sodium Channels in Rat Brain
47. The Uncertainty of Confidence.
48. Electrophysiology of Sipatrigine: A Lamotrigine Derivative Exhibiting Neuroprotective Effects
49. Vicious Cycle Involving Na+Channels, Glutamate Release, and NMDA Receptors Mediates Delayed Neurodegeneration through Nitric Oxide Formation
50. Evaluation of the Novel Neuroprotective Agent BW619C89 in the Middle Cerebral Artery Occlusion Model of Focal Ischemia in the Spontaneously Hypertensive Rat and Normotensive Fischer 344 Rat
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.